Aurobindo Pharma merges Pharmacin BV with Agile Pharma BV
Hyderabad: Aurobindo Pharma Limited has announced the merger of its two wholly owned step-down subsidiaries - Pharmacin B.V. and Agile Pharma B.V. Both the companies are incorporated in the Netherlands.
Effective July 1, 2025, Pharmacin B.V. has been merged with its holding company, Agile Pharma B.V., to enhance the substantive character of Agile with business activity and also saving regulatory and compliance expenses.
For the financial year ending March 31, 2025, Pharmacin B.V. posted a turnover of Rs 197.9 million, while Agile Pharma B.V. reported a turnover of Rs 66.4 million.
Both companies are involved in the manufacturing and marketing of pharmaceutical products.
In June, Aurobindo incorporated a new wholly owned subsidiary in the United States through its arm Aurobindo Pharma USA Inc. The newly formed entity, CRESEDEMO PHARMA LLC, was incorporated on June 13, 2025, with the aim of expanding the company’s pharmaceutical products business in the US market.
Read also: Aurobindo Pharma arm incorporates new subsidiary in US
Earlier, in May, Curateq Biologics Private Limited, another wholly owned subsidiary of the Company, incorporated a new wholly owned subsidiary in the Netherlands by the name of CuraTeQ Biologics B.V.
Read also: Aurobindo Pharma arm Curateq Biologics incorporates new wholly owned subsidiary in Netherlands
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.